NexgenRx Inc.  

(Public, CVE:NXG)   Watch this stock  
Find more results for David C. Loucks
0.000 (0.00%)
Delayed:   10:18AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.14 - 0.84
Open     -
Vol / Avg. 0.00/106,422.00
Mkt cap 9.40M
P/E     -
Div/yield     -
EPS 0.00
Shares 58.77M
Beta 0.07
Inst. own     -
Jul 27, 2016
Q2 2016 NexgenRx Inc Earnings Release

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 3.39% -4.01%
Operating margin 3.39% -4.01%
EBITD margin - -6.71%
Return on average assets 27.59% -26.88%
Return on average equity - -
Employees 20 -
CDP Score - -


185 the West Mall Suite 600
+1-416-6953393 (Phone)
+1-416-6951635 (Fax)

Website links


NexgenRx Inc. (NexgenRx) administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using computer software. The Company is engaged in the sale of its administration and health benefit claims adjudication services to organizations managing health benefit plans on behalf of plan sponsors, such as employers and associations, among others, and to the Canadian plan sponsors providing an Administrative Services Only (ASO) health benefit plan to their plan members. The health benefit claims include drug, dental, extended health and healthcare spending account claims. The Company sells its service on a fee-per-transaction basis, in addition to per member administration fees. The Company's Web-based product,, offers a platform, which allows various extended health providers to submit claims on behalf of their patients for benefits through a Web portal.

Officers and directors

Thomas F. Corcoran Chairman of the Board
Ronald C. Loucks President, Chief Executive Officer, Director
Taba Merrikh Acting Chief Financial Officer
Patrick G. Crowley Director
Barry J. Reiter Director
Age: 66
Ralph Soberano Director
David A. Rosenkrantz Independent Director